AC Immune SA Files 20-F for FY 2024
Ticker: ACIU · Form: 20-F · Filed: Mar 13, 2025 · CIK: 1651625
| Field | Detail |
|---|---|
| Company | Ac Immune SA (ACIU) |
| Form Type | 20-F |
| Filed Date | Mar 13, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 20-F, annual-report, pharmaceuticals
TL;DR
AC Immune SA dropped its 2024 20-F, check financials.
AI Summary
AC Immune SA filed its 20-F report for the fiscal year ending December 31, 2024. The company, incorporated in V8 and headquartered at EPFL Innovation Park, Lausanne, Switzerland, operates in the Pharmaceutical Preparations sector. The filing includes financial data and operational details for the period.
Why It Matters
This filing provides investors and stakeholders with a comprehensive overview of AC Immune SA's financial performance and business operations for the fiscal year 2024, crucial for assessing the company's health and future prospects.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, AC Immune SA faces inherent risks related to drug development, regulatory approvals, and market competition, which are detailed in its 20-F filing.
Key Numbers
- 2024-12-31 — Fiscal Year End (The report covers the period ending on this date.)
- 2025-03-13 — Filing Date (The date the 20-F was officially filed with the SEC.)
- 0001651625 — Central Index Key (Unique identifier for AC Immune SA in the SEC system.)
Key Players & Entities
- AC Immune SA (company) — Filer of the 20-F report
- EPFL INNOVATION PARK, BUILDING B (location) — Business and mailing address
- 1015 LAUSANNE (location) — City of business and mailing address
- V8 (location) — State of incorporation
FAQ
What is AC Immune SA's primary business sector?
AC Immune SA operates in the Pharmaceutical Preparations sector, as indicated by its Standard Industrial Classification code [2834].
Where is AC Immune SA headquartered?
AC Immune SA is headquartered at EPFL Innovation Park, Building B, 1015 Lausanne, Switzerland.
What is the SEC file number for AC Immune SA?
The SEC file number for AC Immune SA is 001-37891.
When was the 20-F filing submitted?
The 20-F filing was submitted on March 13, 2025.
What is the fiscal year end for AC Immune SA?
AC Immune SA's fiscal year ends on December 31.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on March 13, 2025 regarding AC Immune SA (ACIU).